News | Cath Lab | August 15, 2017

Safety-Net vs. Non-Safety-Net Hospitals Deliver Similar PCI Outcomes

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals

NCDR CathPCI Registry data shows in-hospital mortality only marginally higher for PCIs at safety-net hospitals.

Aug. 15, 2017 – Patients undergoing percutaneous coronary intervention (PCI) at safety-net hospitals experienced similar outcomes as patients treated at non-safety-net hospitals, according to research published Aug. 7 issue of JACC: Cardiovascular Interventions. Read the abstract.

Safety-net hospitals in the U.S. serve the nation’s most vulnerable patients, with a focus on providing quality care to patients who are low income and/or uninsured or underinsured, as well as to patients who have insurance. Notably, safety-net hospitals may have fewer resources than other hospitals. In this study, a safety-net hospital was defined as having a PCI volume of at least 10 percent for patients without insurance, based on the Agency of Healthcare Quality and Research definition.

“The patients treated at safety-net hospitals often have critical heart problems and other health issues that, in many cases, have not been adequately managed,” said senior study author John Ambrose, M.D., FACC, emeritus chief of cardiology at the University of California, San Francisco (USCF-Fresno) in Fresno, and professor of medicine at UCSF. “Therefore, the fact that these hospitals are able to keep mortality rates low and achieve these outcomes when performing PCI — nearly matching non-safety net hospitals—is quite remarkable.”

The investigators used data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) CathPCI Registry from 2009 to 2015. They analyzed data from 3,746,961 patients who underwent PCI at 282 safety-net hospitals and 1,134 non-safety-net hospitals. The results showed risk-adjusted in-hospital mortality was only marginally higher in the safety-net hospitals (at four additional patients per 1,000 cases of PCI) than in non-safety-net-hospitals. Patients who went to safety-net hospitals tended to be younger, had more risk factors and more often entered through the emergency department because of a heart attack.

The study also found that both types of hospitals had similar rates of risk-adjusted bleeding and acute kidney injury, which are adverse events associated with PCI procedures. The results of the study are limited to the events that occurred while in the hospital.

“Clinical care is often complex. Because of that, it can be hard to make comparisons to understand what type of care is contributing to a positive outcome and what isn’t,” Ambrose said. “However, with this study, we now know that the hospital itself was not a significant factor in determining how well a patient did after their PCI procedure. The similarities we found also suggested that we can use the current NCDR risk model as a foundation for future comparisons between safety-net and non-safety-net hospitals.”

In an accompanying editorial, Theodore A. Bass, M.D., said that in addition to being vulnerable, the patients studied frequently have little or no ability to select their access to health care institutions or medical providers based on quality outcomes. He added that the study is particularly timely because of the discussion about health care legislation that has the potential to substantially affect resources for safety-net hospitals.

For more information: JACC.org

 

Related ACC NCDR Data Studies:

Study Finds Significant Variability in Doctors' Angioplasty Death Rates

Radial Access, Same-Day Cardiac Procedure Could Save $300 Million Annually

New Report Highlights National Trends in Heart Disease Treatments

Better Prognosis for Some PCI Patients When Operators Perform More Procedures

Radial Access Adoption in the United States

 

Reference:

1. Tushar Acharya, Adam C. Salisbury, John A. Spertus, et al. “In-Hospital Outcomes of Percutaneous Coronary Intervention in America’s Safety Net, Insights From the NCDR Cath-PCI Registry.” JACC: Cardiovascular Interventions. Volume 10, Issue 15, August 2017 DOI: 10.1016/j.jcin.2017.05.042
 

 

 

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init